Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

PURPOSE: Long-term survival rates for older patients with newly diagnosed acute myeloid leukemia (AML) are extremely low. Previous observational studies suggest that allogeneic hematopoietic stem-cell transplantation (HSCT) may improve overall survival (OS) because of lower rates of relapse. We soug...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Devine, Steven M., Owzar, Kouros, Blum, William, Mulkey, Flora, Stone, Richard M., Hsu, Jack W., Champlin, Richard E., Chen, Yi-Bin, Vij, Ravi, Slack, James, Soiffer, Robert J., Larson, Richard A., Shea, Thomas C., Hars, Vera, Sibley, Alexander B., Giralt, Sergio, Carter, Shelly, Horowitz, Mary M., Linker, Charles, Alyea, Edwin P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2015
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4658453/
https://ncbi.nlm.nih.gov/pubmed/26527780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.7273
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky